Transient Interferon-Driven Natural Killer Cell Activation in Acute Hepatitis C
The Journal of Infectious Diseases · 2025
DOI: 10.1093/infdis/jiaf654 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Benedikt Strunz und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. Hauptthemen laut MEDLINE: Killer Cells, Natural, Hepatitis C, Lymphocyte Activation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, European Union's Horizon Europe Framework Programme, Swedish Research Council.
Abstract (Originalsprache)
Acute infection with hepatitis C virus (HCV) is a rare event that can be treated successfully with direct-acting antivirals (DAAs). As natural killer (NK) cells play an important role during the natural course of acute HCV, we assessed the NK cell compartment via flow cytometry and single-cell sequencing in longitudinally sampled patients with acute HCV and compared this to healthy controls and patients with chronic HCV. At the transcriptomic level, we identified a subset of highly activated NK cells with a robust type I interferon imprint. While the population of activated NK cells vanished after DAA-mediated cure, a long-term phenotypic imprint of infection was observed in comparison to healthy controls. Collectively, these data suggest an interferon-driven rise of an activated NK cell population during acute hepatitis C that is largely restored upon viral clearance. This study provides insights into the immunological basis for successful antiviral response to hepatitis C.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
- Centre for Individualised Infection Medicine (CIIM), Helmholtz-Centre for Infection Research (HZI) and Hannover Medical School, Hannover, Germany.
- TWINCORE, Centre for Experimental and Clinical Infection Research, Helmholtz-Centre for Infection Research (HZI) and Hannover Medical School, Hannover, Germany.
- Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
- German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, Braunschweig, Germany.
- Cluster of Excellence RESIST (EXC2155), Hannover Medical School, Hannover, Germany.
ORCID-Profile: Benedikt Strunz, Marija Jankovic, Annika Niehrs, Heiner Wedemeyer, Niklas K Björkström
Förderung
- European Research Council
- European Union's Horizon Europe Framework Programme
- Swedish Research Council
- Swedish Cancer Society
- Swedish Foundation for Strategic Research
- Knut and Alice Wallenberg Foundation
- Center for Innovative Medicine
- Karolinska Institutet
Zitieren
APA
Strunz, B., Zhan, Q., Khera, T., Hengst, J., Jankovic, M., Deterding, K., Niehrs, A., Cornberg, M., Xu, C. J., Wedemeyer, H., Björkström, N. K., & HepNet Acute HCV IV Study Group (2025). Transient Interferon-Driven Natural Killer Cell Activation in Acute Hepatitis C. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf654
Vancouver
Strunz B, Zhan Q, Khera T, Hengst J, Jankovic M, Deterding K, et al. Transient Interferon-Driven Natural Killer Cell Activation in Acute Hepatitis C. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiaf654
BibTeX
@article{Strunz2025,
author = {Strunz, Benedikt and Zhan, Qiuyao and Khera, Tanvi and Hengst, Julia and Jankovic, Marija and Deterding, Katja and Niehrs, Annika and Cornberg, Markus and Xu, Cheng-Jian and Wedemeyer, Heiner and Björkström, Niklas K and HepNet Acute HCV IV Study Group, HepNet Acute HCV IV Study Group},
title = {Transient Interferon-Driven Natural Killer Cell Activation in Acute Hepatitis C},
journal = {The Journal of Infectious Diseases},
year = {2025},
doi = {10.1093/infdis/jiaf654}
}
EUVIMED